Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF25 divergent transcript (ZNF25-DT) is a long non-coding RNA gene located in the genome near the ZNF25 (Zinc finger protein 25) coding gene. "Divergent transcript" refers to a class of lncRNAs transcribed from the region antisense or near to a known protein-coding gene, often sharing a bidirectional promoter region but transcribed in the opposite orientation. The specific biological function and disease relevance of ZNF25-DT remain uncharacterized in the scientific literature as of the present search. There is no evidence that ZNF25-DT serves as a direct therapeutic target (such as a receptor, enzyme, or transporter), nor are any drugs currently known to target this non-coding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF25 divergent transcript (ZNF25-DT).